Form 4 for LH Labcorp
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0001127602-22-005018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-12 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | — | +284 | 5,571 | +5% | — |
| D | 2022-02-15 | 2022-02-14 | LH | van der Vaart Sandra D | EVP, CLO | F - Tax | $272.68 | -77 | 5,494 | -1% | -$21.0K |
| DM | 2022-02-15 | 2022-02-11 | LH | van der Vaart Sandra D | EVP, CLO | A - Grant | $0.00 | +3,970 | 3,100 | New | $0 |
| D | 2022-02-15 | 2022-02-12 | LH | van der Vaart Sandra D | EVP, CLO | M - OptEx | $0.00 | -284 | 1,644 | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-12 | M | A | 284 | — | 5,571.02 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| 2 | Common | Common Stock | 2022-02-14 | F | D | 77 | $272.68 | 5,494.02 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-02-11 | A | A | 870 | $0.00 | 1,928 | D | — · — to — | 870 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2023. |
| 4 | Derivative | Restricted Stock Unit | 2022-02-12 | M | D | 284 | $0.00 | 1,644 | D | — · — to — | 284 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F7) The Restricted Stock Units vested in three equal annual installments beginning on February 12, 2020 and are now fully vested. |
| 5 | Derivative | Non-qualified Stock Options | 2022-02-11 | A | A | 3,100 | $0.00 | 3,100 | D | $276.26 · 2023-02-11 to 2032-02-10 | 3,100 Common Stock | (F5) Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. (F6) The option vests in three equal annual installments beginning on the date reflected in this column. |